Literature DB >> 31327521

Association between reduced myocardial contraction fraction and cardiovascular disease outcomes: The Multi-Ethnic Study of Atherosclerosis.

Marwah Abdalla1, Elvis A Akwo2, David A Bluemke3, João A C Lima4, Daichi Shimbo5, Mathew S Maurer5, Alain G Bertoni6.   

Abstract

BACKGROUND: The myocardial contraction fraction (MCF: stroke volume to myocardial volume) is a volumetric measure of left ventricular myocardial shortening. We examined the relationship of MCF, measured by cardiac magnetic resonance imaging (cMRI), to incident cardiovascular (CV) events within the Multi-Ethnic Study of Atherosclerosis (MESA).
METHODS: Participants (n = 5000, aged 45-84 years) underwent cMRI. PRIMARY OUTCOME: CVD events (myocardial infarction, resuscitated cardiac arrest, stroke, coronary heart disease: CHD death, and stroke death). SECONDARY OUTCOMES: CHD and heart failure (HF) events. Cox proportional hazards regression was used to estimate the hazard ratio (HR) and 95% confidence intervals (CI) for outcomes.
RESULTS: There were 299 incident CVD, 188 CHD, and 151 HF events over 10.2 years. The lowest MCF quartile was associated with an increased risk for incident CVD [HR 2.42, CI: 1.58-3.72], CHD [HR 2.32, CI: 1.36-3.96] and HF events [HR 1.99, CI: 1.15-3.44]. In a model adjusted for demographics, CV risk factors, antihypertensive and lipid-lowering medication use, each standard deviation decrease in MCF was associated with incident CVD [HR 1.42, CI: 1.23-1.64], CHD [HR 1.40, CI: 1.17-1.67] and HF [HR 1.58, CI: 1.30-1.94]. In a subgroup analysis of participants with preserved ejection fraction and without left ventricular hypertrophy, the lowest MCF quartile and each standard deviation decrease in MCF was also associated with an increased risk for incident CVD in fully-adjusted analyses.
CONCLUSIONS: MCF is a novel measure that can be measured using cMRI. In this multi-ethnic cohort, MCF is a measure that can be used to predict incident CVD events.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Epidemiology; Myocardial contraction fraction

Mesh:

Year:  2019        PMID: 31327521      PMCID: PMC7175692          DOI: 10.1016/j.ijcard.2019.07.040

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  42 in total

Review 1.  Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction.

Authors:  Lee R Goldberg; Mariell Jessup
Journal:  Circulation       Date:  2006-06-20       Impact factor: 29.690

2.  Relation of the Myocardial Contraction Fraction, as Calculated from M-Mode Echocardiography, With Incident Heart Failure, Atherosclerotic Cardiovascular Disease and Mortality (Results from the Cardiovascular Health Study).

Authors:  Mathew S Maurer; William J H Koh; Traci M Bartz; Sirish Vullaganti; Eddy Barasch; Julius M Gardin; John S Gottdiener; Bruce M Psaty; Jorge R Kizer
Journal:  Am J Cardiol       Date:  2016-12-18       Impact factor: 2.778

Review 3.  Legacy of MESA.

Authors:  Jean L Olson; Diane E Bild; Richard A Kronmal; Gregory L Burke
Journal:  Glob Heart       Date:  2016-09

4.  Subclinical atherosclerosis and incipient regional myocardial dysfunction in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Verônica R S Fernandes; Joseph F Polak; Thor Edvardsen; Benilton Carvalho; Antoinette Gomes; David A Bluemke; Khurram Nasir; Daniel H O'Leary; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2006-05-30       Impact factor: 24.094

5.  Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudy.

Authors:  M H Olsen; K Wachtell; J N Bella; V Palmieri; E Gerdts; G Smith; M S Nieminen; B Dahlöf; H Ibsen; R B Devereux
Journal:  J Hum Hypertens       Date:  2004-06       Impact factor: 3.012

Review 6.  Myocardial tissue tagging with cardiovascular magnetic resonance.

Authors:  Monda L Shehata; Susan Cheng; Nael F Osman; David A Bluemke; João A C Lima
Journal:  J Cardiovasc Magn Reson       Date:  2009-12-21       Impact factor: 5.364

7.  A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the Dallas heart study.

Authors:  Michel G Khouri; Ronald M Peshock; Colby R Ayers; James A de Lemos; Mark H Drazner
Journal:  Circ Cardiovasc Imaging       Date:  2010-01-08       Impact factor: 7.792

8.  Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study.

Authors:  Jorge R Kizer; Donna K Arnett; Jonathan N Bella; Mary Paranicas; D C Rao; Michael A Province; Albert Oberman; Dalane W Kitzman; Paul N Hopkins; Jennifer E Liu; Richard B Devereux
Journal:  Hypertension       Date:  2004-05-03       Impact factor: 10.190

9.  Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy.

Authors:  Frank Grothues; Gillian C Smith; James C C Moon; Nicholas G Bellenger; Peter Collins; Helmut U Klein; Dudley J Pennell
Journal:  Am J Cardiol       Date:  2002-07-01       Impact factor: 2.778

10.  Diastolic function assessed from tagged MRI predicts heart failure and atrial fibrillation over an 8-year follow-up period: the multi-ethnic study of atherosclerosis.

Authors:  Bharath Ambale-Venkatesh; Anderson C Armstrong; Chia-Ying Liu; Sirisha Donekal; Kihei Yoneyama; Colin O Wu; Antoinette S Gomes; Gregory W Hundley; David A Bluemke; Joao A Lima
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-10-20       Impact factor: 9.130

View more
  5 in total

1.  Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population.

Authors:  Julia Kozlitina; Sonia Garg; Mark H Drazner; Susan A Matulevicius; Colby Ayers; John Overton; Jeffrey Reid; Aris Baras; Krishnasree Rao; Ambarish Pandey; Jarett Berry; James A de Lemos; Justin L Grodin
Journal:  J Card Fail       Date:  2021-10-09       Impact factor: 5.712

2.  Comparison of Nonclassic and Classic Phenotype of Hypertrophic Cardiomyopathy Focused on Prognostic Cardiac Magnetic Resonance Parameters: A Single-Center Observational Study.

Authors:  Magdalena Stachera; Paweł Przybyło; Katarzyna Sznajder; Marek Gierlotka
Journal:  Diagnostics (Basel)       Date:  2022-04-28

3.  Glycemic status, non-traditional risk and left ventricular structure and function in the Jackson Heart Study.

Authors:  Chizobam Ani; David Shavlik; Synnove Knutsen; Islam Abudayyeh; Jimmie Banta; Emily O'Brien; Robert J Mentz; Alain G Bertoni; Gary Fraser
Journal:  BMC Cardiovasc Disord       Date:  2022-04-21       Impact factor: 2.174

4.  Echocardiographic Investigation of Low-Flow State in a Hispanic/Latino Population.

Authors:  Patrick M Kozak; Min Pu; Katrina Swett; Martha L Daviglus; Mayank M Kansal; Daniela Sotres-Alvarez; Sonia G Ponce; Robert Kaplan; Mario Garcia; Carlos J Rodriguez
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2022-07-31

5.  Myocardial contraction fraction predicts mortality for patients with hypertrophic cardiomyopathy.

Authors:  Hang Liao; Ziqiong Wang; Liming Zhao; Xiaoping Chen; Sen He
Journal:  Sci Rep       Date:  2020-10-12       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.